Susquehanna International Group, LLP G1 Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	BUY	$2.2 - $4.98 $107,140 - $242,526	48,700 Added 35.52%	185,800 $423,000
Q1 2024 May 07, 2024	BUY	$2.1 - $4.83 $97,020 - $223,146	46,200 Added 50.83%	137,100 $592,000
Q4 2023 Feb 14, 2024	BUY	$1.12 - $3.73 $62,720 - $208,880	56,000 Added 160.46%	90,900 $277,000
Q3 2023 Nov 14, 2023	SELL	$1.22 - $2.67 $28,914 - $63,279	-23,700 Reduced 40.44%	34,900 $50,000
Q2 2023 Aug 11, 2023	BUY	$2.46 - $3.14 $78,474 - $100,166	31,900 Added 119.48%	58,600 $145,000
Q1 2023 May 16, 2023	SELL	$2.57 - $8.16 $28,013 - $88,944	-10,900 Reduced 28.99%	26,700 $71,000
Q4 2022 Feb 14, 2023	BUY	$5.19 - $13.5 $46,710 - $121,500	9,000 Added 31.47%	37,600 $204,000
Q3 2022 Nov 14, 2022	BUY	$5.17 - $16.99 $56,353 - $185,190	10,900 Added 61.58%	28,600 $357,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.